Sort   by:  
 Page size 
UnknownPatient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
Not available
S-EPMC4876313 | biostudies-literature
UnknownUsing three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals.
Not available
S-EPMC9385826 | biostudies-literature
UnknownSurvival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance.
Not available
S-EPMC11405037 | biostudies-literature
UnknownWhat Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial.
Not available
S-EPMC6364092 | biostudies-literature
UnknownHealth-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Not available
S-EPMC8906451 | biostudies-literature
Sort   by:  
 Page size